Vous avez cherché: alzheimer (Anglais - Maltais)

alzheimer's disease
il-marda ta’ alzheimer

alzheimer's disease (communication)
il-marda ta’ alzheimer (komunikazzjoni)

this is supported by alzheimer europe.
dan huwa appoġġjat minn alzheimer europe.

clinical studies in alzheimer's dementia
studji kliniċi b’dimenzja ta’ alzheimer

combating alzheimer's and neurodegenerative diseases.
il-ġlieda kontra l-alzheimer u l-mard newro-deġenerattiv.

patients with alzheimer's disease may lose weight.
pazjenti li jbatu bil-marda ta’ alzheimer jistgħu jonqsu fil-piż.

information on amyloid pathology in alzheimer’s disease;
tagħrif dwar il-patoloġija tal-amilojdi fil-marda ta’ alzheimer;

research joint programming in the fight against alzheimer's
progammar konġunt tar-riċerka għall-ġlieda kontra l-alzheimer's

combating alzheimer's and neurodegenerative diseases - council conclusions
il-ġlieda kontra l-alzheimer u l-mard newro-deġenerattiv - konklużjonijiet tal-kunsill

alzheimer's disease remains under-diagnosed in the eu.
il-marda ta’ alzheimer għadha mhijiex iddijanjostikata biżżejjed fl-ue.

treatment of patients with moderate to severe alzheimer's disease.
kura ta’ pazjenti bil-marda ta’ alzheimer moderata għal severa.

exelon has been studied in mild to moderately severe alzheimer’ s disease.
exelon ġie studjat fil- marda ta 'alzheimer minn ħafifa għal moderatament gravi.

hallucinations have mainly been observed in patients with severe alzheimer´s disease.
alluċinazzjonijiet dehru l- aktar f’ pazjenti bil- marda ta ’ alzheimer severa.

alzheimer's disease has been associated with depression, suicidal ideation and suicide.
il-marda ta’ alzheimer kienet assoċjata ma’ dipressjoni, ħsibijiet ta’ suwiċidju u suwiċidju.

axura was more effective than placebo at controlling the symptoms of alzheimer’s disease.
axura kien iktar effikaċi mill-plaċebo fil-kontroll tas-sintomi tal-marda ta’ alzheimer.

alzheimer's disease international estimates that worldwide 104 million people will have dementia by 2050.
l-alzheimer’s disease international jistma li sal-2050 104 miljun ruħ ser ibatu minn dimenzja madwar id-dinja.

patients with alzheimer’s disease may lose weight whilst taking cholinesterase inhibitors, including rivastigmine.
pazjenti bil-marda ta’ alzheimer jistgħu jitilfu l-piż waqt li jkunu qed jieħdu inibituri ta’ cholinesterase, inkluż rivastigmine.

neuro-degenerative diseases associated with ageing and in particular alzheimer's disease – council conclusions............................................................................................................................................................
mard newrodeġenerattiv assoċjat max-xjuħija u b'mod partikolari l-marda ta' alzheimer – konklużjonijiet tal-kunsill.................................................................................................................................................